[Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)]. [electronic resource]
Producer: 20171228Description: S84-S98 p. digitalISSN:- 1769-6917
- Antineoplastic Agents -- therapeutic use
- Bortezomib -- therapeutic use
- Central Nervous System Neoplasms -- prevention & control
- Genetic Markers
- Hematologic Neoplasms -- genetics
- Hematopoietic Stem Cell Transplantation
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Lymphoma -- drug therapy
- Maintenance Chemotherapy -- standards
- Multiple Myeloma -- drug therapy
- Neoplasm, Residual
- Prognosis
- Protein Kinase Inhibitors -- therapeutic use
- Recurrence
- Retreatment -- methods
- Secondary Prevention -- methods
No physical items for this record
Publication Type: Journal Article; Practice Guideline; Review
There are no comments on this title.
Log in to your account to post a comment.